Cargando…
Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
We report on a 79-year-old man diagnosed with localized Merkel cell carcinoma (MCC) who also had acetylcholine receptor antibody (Ach-R-Ab)-positive myasthenia gravis (MG) controlled on prednisolone, mycophenolate and intravenous immunoglobulin (IVIG). His MCC was initially treated with radiation, f...
Autores principales: | Williams, Sarah, Liang, Christina, Guminski, Alexander, Hruby, George, Chan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858387/ https://www.ncbi.nlm.nih.gov/pubmed/35198232 http://dx.doi.org/10.1093/omcr/omac012 |
Ejemplares similares
-
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
por: Zaremba, Anne, et al.
Publicado: (2019) -
Novel Immunotherapies for Myasthenia Gravis
por: Nair, Sruthi S, et al.
Publicado: (2023) -
Benefit and danger from immunotherapy in myasthenia gravis
por: Rodolico, Carmelo, et al.
Publicado: (2021) -
Immunotherapy choice and maintenance for generalized myasthenia gravis in China
por: Zhang, Chao, et al.
Publicado: (2020) -
Immunotherapy for ocular myasthenia gravis: an observational study in Japan
por: Narita, Tomoko, et al.
Publicado: (2023)